In This Article:
LAS VEGAS, NV, March 28, 2024 (GLOBE NEWSWIRE) -- PSYC Corporation (OTCPink: PSYC) (“PSYC” or the “Company”), announces the appointment of Daniel Jaros as Interim CEO and Director, marking a strategic shift towards the online gaming industry. Mr. Jaros brings extensive experience in IT, with a focus on game development, programming, and social media management.
With a number of projects in the realms of gaming, technology, and programming, the Company firmly believes that he has the skills and expertise to excel in this role.
Since 2020, PSYC has operated in the medicinal psychedelic industry, notably through its Psychedelic Spotlight platform.
As part of its transition, PSYC has relinquished ownership of Psychedelic Spotlight to The Spore Group, a partner of Target Media. This move allows PSYC to retire a $350K promissory note debt and retain 1.5% equity in Psychedelic Spotlight.
David Flores, former CEO of PSYC, expressed gratitude to shareholders and highlighted the challenges faced in the psychedelic market sector. He expressed confidence in Jaros' leadership, especially in navigating PSYC towards the online gaming industry.
Daniel Jaros, the new Interim CEO and Director, looks forward to leading PSYC into its new chapter, saying “I’m excited by the games the team’s been working on and the new direction the company is taking. Having been involved with mobile game development previously, it’s a market that is constantly growing and brings in reliable repeat businesses.”
Forward-Looking Statements Disclaimer Applicable to this Press Release and the Company’s Video:
No information contained in this Press Release video should be construed in any way whatsoever as an offer to sell or buy the Company’s securities.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website and is not incorporated by reference into such reports. No information contained in this press release should be construed as any indication whatsoever of the Company’s future, revenues, results of operations or stock price.